About this trial
The goal of this prospective observational cohort study is to establish a comprehensive clinical prediction rule integrating clinical characteristics, point-of-care testing (POCT) of NT-proBNP, an 8-point LUS, and a rapid cardiac assessment using bedside echocardiography for diagnosing acute heart failure (AHF) in the emergency department. A clinical prediction rule with high diagnostic accuracy will minimize delays and misdiagnoses, as well as the potential harm they may cause to patients. The primary outcome measure is the adjudicated AHF diagnosis. Secondary outcome measures include ED and discharge diagnosis of the patients.
Eligibility criteria
Qualifiers
Adult (aged ≥ 18 years)
Suspected AHF or acute dyspnea
Symptoms include shortness of breath, swelling of legs, orthopnea, paroxysmal nocturnal dyspnoea, exertional dyspnea or weight gain
Disqualifiers
Trauma patients
Pregnancy
Unstable patients requiring invasive airway intervention
Patients who refuse to participate
Trial design
Treatments tested in this trial
- Acute Heart Failure Diagnostic Method
Treatment groups
Sponsors and collaborators
Chinese University of Hong Kong
Lead sponsor
Prince of Wales Hospital, Shatin, Hong Kong
Collaborator
The University of Hong Kong
Collaborator
Tuen Mun Hospital, Hospital Authority, Hong Koong
Collaborator
Queen Mary Hospital, Hong Kong
Collaborator